TransMolecular's Series C Round

TransMolecular raised a round of funding on March 22, 2004.

Transmolecular is a biotechnology company targeting disorders of the central nervous system. The company is committed to discovering, developing, and commercializing targeted therapies for glioma, met…

Articles about TransMolecular's Series C Round: